Most components in the nucleus are in a state of dynamic equilibrium maintained by the rapid mobility of nuclear proteins within and between compartments. Mobility is believed to reflect transient binding, but the identity of the binding sites and the function of the transient interactions are a matter of debate. Furthermore, we know little about how these processes may be regulated. Here, we investigate the nature and regulation of transcription factor binding and mobility in the nucleus of yeast cells. Using the Ace1p transcriptional activator, we show that nonspecific DNA binding interactions seem to have a role in retarding Ace1p nuclear mobility. Surprisingly, we find that this binding is a regulated process using a chromatin remodeller to speed up Ace1p interactions at nonspecific DNA sites. Our results suggest that transcription factor mobility represents a diffusion-driven, rapid sampling of nonspecific DNA sites, and that chromatin remodellers accelerate this genomic search process.
INTRODUCTION
As revealed by fluorescence recovery after photobleaching (FRAP), many proteins in the nucleus, including several transcription factors, are highly mobile. Although they move rapidly, these proteins do not move as fast as a freely diffusing molecule such as green fluorescent protein (GFP; Misteli, 2001 ). This implies that, similar to other nuclear proteins, transcription factors are retarded by binding interactions of some sort as they move through the nucleus. Several uncertainties remain to be clarified about this behaviour, including the identity of the binding sites and whether binding is specific or regulated.
Most of our knowledge of transcription factor mobility comes from steroid receptors, the mobility of which is known to require energy, proteasome function and molecular chaperones (Stenoien et al, 2001; Schaaf & Cidlowski, 2003; Elbi et al, 2004) . Some evidence suggests that these transcription factors are normally bound to the nuclear matrix (Stenoien et al, 2001; Schaaf & Cidlowski, 2003) , but other data argue against this (Sprague et al, 2004) .
Here, we have used yeast molecular genetics to identify the natural binding state of a transcription factor, Ace1p, which is required in yeast for copper detoxification (Furst et al, 1988) . The Ace1p protein has a simple domain structure that allows a direct test of how DNA binding contributes to nuclear mobility. In addition, by mutating other cellular factors, we have investigated how mobility of Ace1p is regulated. These studies suggest that Ace1p mobility corresponds to the rapid sampling of nonspecific DNA binding sites, and that a chromatin remodeller normally accelerates this process.
RESULTS AND DISCUSSION Mobility is retarded by nonspecific DNA binding
Our carboxy-terminal fusion of GFP to Ace1p was functional. It rescued the copper sensitivity of the ace1 knockout (data not shown), and localized to the nucleus ( Fig 1A) consistent with Szczypka & Thiele (1989) . FRAP recoveries for Ace1p-GFP were obtained using a 0.7-mm-diameter circular bleach spot (Fig 1B) positioned at random locations within the B2-mm-diameter diploid yeast nucleus. The fusion protein was overexpressed B3-fold in these cells (B5,000 Ace1p-GFP molecules per nucleus), on the basis of measurements of known concentrations of GFP imaged under identical conditions. These relatively low levels and the small bleach spots used here necessitated averaging of B20 or more data sets to produce reasonably smooth FRAP recovery curves for Ace1p-GFP (Fig 1C) . The averaged FRAP curves were then fitted with models for FRAP recovery described by Sprague et al (2004) . The fitting routine estimates the bleach depth by extrapolating back from the first time point at t ¼ 2 ms. The fitted recovery curves are presented here ( Fig 1D, and in all subsequent figures) with the bleach depth normalized to 0, and standard errors of the mean indicated at each time point.
FRAPs of Ace1p-GFP revealed rapid exchange typical of other transcription factors (McNally et al, 2000; Stenoien et al, 2001; Schaaf & Cidlowski, 2003) . However, the Ace1p-GFP recovery was significantly slower than that of GFP alone (Fig 2A) , predicting a mass of 1.4 MDa for Ace1p-GFP (see Methods), far in excess of the real mass (55 kDa). This suggests that Ace1p-GFP recoveries are retarded by binding interactions. By fitting a model for FRAP recoveries (Sprague et al, 2004) to the Ace1p-GFP FRAP data, we have quantitatively accounted for these binding interactions and defined the mechanism of Ace1p-GFP movement in the nucleus. The averaged Ace1p-GFP recoveries were well fitted by an effective diffusion model (Sprague et al, 2004 ) using a single parameter for recovery rate (Figs 1D, 2A) . In a FRAP recovery, effective diffusion arises when the time to associate with a binding site is much faster than the time to diffuse across the bleach spot. Therefore, during the time frame of the FRAP recovery, each Ace1p molecule is transiently bound at many sites, moving from one site to the next by simple diffusion. When binding interactions are altered in such a scenario, small changes in the FRAP curve result, essentially because the diffusive component of the curve has been unaffected ( Fig 2B) . Therefore, even small changes in the FRAP curves may indicate significant changes in binding.
To investigate sites for Ace1p binding, we removed its DNA binding domain (DBD; Brown et al, 2002) . This mutant protein no longer localized to the nucleus, so we constructed a DBD À nuclear localization signal (NLS) to ensure that FRAPs of the Dynamic interactions of a transcription factor with DNA T.S. Karpova et al DBD À mutant were performed in nuclei. For valid comparison, we also added an NLS to Ace1p-GFP and performed FRAPs of both the full-length and mutant proteins. The DBD À mutant recovered faster than the full-length protein (Fig 2C) , demonstrating that Ace1p-GFP mobility is normally retarded by DNA binding. This DNA binding is likely to be nonspecific, as only a negligible fraction of the total Ace1p-GFP fluorescence throughout the nucleus can arise from binding at known specific sites. There are at most 32-64 Ace1p-specific sites in the yeast genome, and virtually all are clustered at the same amplified chromosomal locus CUP1 (Welch et al, 1983) . We conclude that DNA is a target of Ace1p binding and that much of this binding is probably nonspecific.
Our FRAP analysis enables an in vivo estimate of a nonspecific DNA binding constant. Using the effective diffusion fit, and estimating a free DNA concentration of B1-10 mM (see Methods), we obtain a range for the in vivo association constant K a B10 2 -10 3 M À1 . This is an order of magnitude estimate owing to the approximations made in FRAP modelling (see Methods) and our ignorance about the free DNA concentration in a live cell. The lower bound for K a presumes that all DNA sites are accessible in vivo, whereas the upper bound presumes that only 10% of the sites are available, with the remainder masked by chromatin. To compare this estimate of K a with typical in vitro values of nonspecific DNA binding, we must account for the presence of histones in vivo, which neutralize approximately half the DNA charge (Clark & Kimura, 1990) . Here an order-of-magnitude estimate predicts that K a in vivo should be approximately the square root of K a in vitro (see Methods). As the in vitro data for nonspecific DNA binding range from 10 4 to 10 5 M À1 (Oda & Nakamura, 2000) , they are consistent with our in vivo estimate of 10 2 -10 3 M À1 for Ace1p nonspecific DNA binding.
Regulation of mobility by a chromatin remodeller
To test if Ace1p nonspecific DNA binding was regulated, we investigated chromatin remodellers. Several in vitro studies as well as an in vivo chromatin immunoprecipitation analysis have suggested that chromatin remodellers can displace transcription factors from specific DNA binding sites (Fletcher et al, 2002; Kassabov et al, 2002; Moreau et al, 2003; Nagaich et al, 2004) . To test an in vivo role for chromatin remodellers at nonspecific DNA sites, we performed FRAPs of Ace1p-GFP in disruption mutants for different remodellers: swi2D (an ATPase of the SWI/SNF complex; Cairns et al, 1994; Cote et al, 1994) ; rsc1D, rsc2D (subunits of the RSC1 and RSC2 complexes; Cairns et al, 1996 Cairns et al, , 1999 ; rad54D (an ATPase with chromatin-remodelling activity; Alexeev et al, 2003) ; isw1D, isw2D (ATPases of ISWI1 and ISWI2 complexes; Tsukiyama et al, 1999) ; and chd1D (an ATPase of CHD/Mi2 complex; Tran et al, 2000) . In most disruption mutants (Fig 3) , FRAP recoveries of Ace1p-GFP were not significantly different from wild type, with the exception of rsc2D, where we were able to detect a significant slowdown (Fig 4A) . This slowdown was not due to a global change in nuclear structure or mobility arising in rsc2D, because GFP nuclear recoveries were unaffected in the rsc2D strain (Fig 4B) . Interestingly, slower Ace1p-GFP recoveries did not occur after loss of the related RSC1 complex (Figs 4C and 3F) . The RSC1 complex differs from the RSC2 complex in only one subunit (Rsc1p replaces Rsc2p), and the two complexes bind to many of the same sites (Ng et al, 2002) . Our FRAP data therefore suggest a highly specific role for Rsc2p.
In principle, chromatin-remodelling activity could influence transcription factor mobility by several mechanisms. The absence of a remodeller should decrease the accessibility of nucleosomal DNA (Längst & Becker, 2001 ), thereby reducing the average 'on' rate of a transcription factor to DNA. Because K a ¼ k on /k off , a reduced k on should yield a reduced K a . However, fits to our FRAP data reveal the opposite, with K a increasing by 1.6-fold in rsc2D.
To account for this increase, any decrease in k on must therefore be compensated for by an even larger decrease in k off . This is in fact consistent with the proposed role of remodellers in catalysing removal of transcription factors from DNA sites (Fletcher et al, 2002; Kassabov et al, 2002; Moreau et al, 2003; Nagaich et al, 2004) . Thus, RSC2 may normally interact directly with Ace1p and catalyse its removal from nonspecific sites. However, an indirect interaction is also possible. As this remodeller is relatively abundant in yeast (Cairns et al, 1996) , it may bind at a multitude of genomic sites and inadvertently disrupt transcription factors bound nonspecifically in its vicinity.
In either of these two scenarios, the decreased mobility of Ace1p seen in the absence of a specific remodeller may reflect genome-wide remodelling action, as suggested by recent studies demonstrating the widespread distribution of remodellers beyond promoter sites (Ng et al, 2002) . Increased mobility of Ace1p would then be a consequence of this global remodelling action, a phenomenon that could have functional significance. Our data suggest that Ace1p nuclear mobility reflects the rapid, diffusiondriven sampling of nonspecific DNA binding sites. This supports the general hypothesis that nuclear protein mobility represents the process of genome-wide search for specific target sites (Phair et al, 2004 ). Our observations not only suggest that this is what Ace1p nuclear mobility reflects but also show that a chromatin remodeller can accelerate this sampling process.
METHODS
Strains and plasmids. Wild type and strains homozygous for disruptions of swi2, rsc1, rsc2, isw1, isw2, rad54 and chd1 were diploids in the BY4743 genetic background isogenic to the SC288C strain (Research Genetics/Invitrogen, Huntsville, AL, USA). Each strain was transformed with either pTSK65 (Ace1p-GFP), pTSK288 (Ace1p-GFP-NLS), pTSK119 (transcriptional activation domain (TAD)-GFP-NLS), pTSK20 (GFP) or pTSK136 (GFP-NLS). To ensure nuclear retention, we added in some cases an NLS to certain constructs, as indicated above. Autonomous plasmids were constructed from the vector p2HG/N792 carrying the yeast constitutive GPD promoter, HIS3 marker and 2 mm plasmid replicator (a gift from Dr S. Lindquist, Whitehead Institute, Cambridge, MA, USA). To construct pTSK65, two fragments were inserted into the vector p2HG/N792: (1) the yeast ACE1 gene that was PCR amplified from genomic DNA using primers CATG GGATCC cgaataaacacacataaataaacaaa ATGGTCGTAATTAACG GGGT (GPD leader sequence in small letters, BamHI site in italics) and CCGAGCGGCCGC TTGTGAATGTGAGTTATGCGA (NotI site in italics); (2) the yeast-enhanced GFP (Cormack et al, 1997) that was PCR amplified from pBM3412 (a gift from Dr M. Johnston, Washington University, St Louis, MO, USA) using primers CATG GCGGCCGCC gctgctgccgctgcagctgctgcagctgcg ATGTCTAAAGGTGAAGAATTATTC (13-ala protein linker in small letters, NotI site in italics) and CCGA CCGCGG TTATTTG TACAATTCATCCATACCATGGGT (SacII site in italics).
To construct pTSK119, a C-terminal fusion of GFP to the TAD of the ACE1 gene was PCR amplified from pTSK65 using primers CATG GGATCC atg AAGGGAGGGTCATGCCACAGAAGG (BamHI site in italics, added ATG codon in small letters) and CCGA CCGCGG TCATCA ggcaacctttctcttcttctttggtggagt TTTGTA CAATTCATCCATACCATGGG (NLS in small letters, SacII site in italics) and inserted into pTSK65.
To construct pTSK136, GFP was PCR amplified from pBM3412 using primers CATG GGATCC cgaataaacacacataaataaacaaa ATGTCTAAAGGTGAAGAATTATTC (GPD leader sequence in small letters, BamHI site in italics) and CCGA CCGCGG TCATCA ggcaacctttctcttcttctttggtggagt TTTGTACAATTCATCCATACCAT GGG (NLS in small letters, SacII site in italics) and inserted into pTSK65.
To construct pTSK20, GFP was PCR amplified from pBM3412 using primers CATG GGATCC cgaataaacacacataaataaacaaa ATGTCTAAAGGTGAAGAATTATTC (GPD leader sequence in small letters, BamHI site in italics) and CCGA GCGGCCGC AGCAGCTGCAGCAGCTGCAGCGGCAGCAGCTTTGTACAATTC ATCCATACCATGGGT (NotI site in italics) and inserted into p2HG/N792 to replace the glucocorticoid receptor.
To construct pTSK288, GFP-NLS fragment was cut out of pTSK119 (Not1-SacII) and inserted into pTSK65 to replace GFP. Microscopy and FRAP. Cultures were grown at 28 1C in CSMhistidine (complete supplement mixture, Bio101 Inc., Vista, CA, USA). Overnight cultures were diluted 1:30 in fresh CSM-histidine and grown for 3-6 h. Cells were concentrated from 500 ml of the culture by centrifugation. Drops (2 ml) were placed on a slide and covered with coverslips.
FRAP experiments were carried out on a Zeiss 510 confocal microscope with a 100 Â and 1.3 NA oil immersion objective. Cells were imaged with a 488 nm laser line from a 40 mW argon laser at low laser intensity (0.75%) to reduce bleaching due to imaging. Bleaching was performed with the 488 nm line operating at 75% laser power. A single iteration was used for the bleach pulse, which lasted 7 ms. The measured diameter of the bleach spot was 0.7 mm. Fluorescence recovery was monitored every 20 ms. All the experiments were repeated at least twice. The total cell number analysed for each experiment was routinely more than 19. For each data set shown, separate FRAPs were performed and then averaged to generate a single FRAP curve. FRAP analysis. Averaged FRAP curves were fitted with a routine that estimates the bleach depth, the recovery rate and the immobile fraction. The immobile fraction for Ace1p-GFP varied from day to day, but was always less than 3%. Bleach depths also varied from day to day, presumably owing to variations in laser power or transmittance. Owing to the variation in these Dynamic interactions of a transcription factor with DNA T.S. Karpova et al chd1Δ has no effect on Ace1p−GFP binding isw1Δ has no effect on Ace1p−GFP binding isw2Δ has no effect on Ace1p−GFP binding rad54Δ has no effect on Ace1p−GFP binding rsc1Δ has no effect on Ace1p−GFP binding swi2Δ has no effect on Ace1p−GFP binding Dynamic interactions of a transcription factor with DNA T.S. Karpova et al parameters, FRAP curves were compared on the basis of the recovery rate. This is determined by all of the FRAP data points, and as described below can be captured for Ace1p-GFP in a single parameter, namely the effective diffusion constant. The FRAP fits presume a homogeneous distribution of binding sites photobleached with a cylindrical bleach pattern. These conditions are only approximately met in real cells, so the resultant estimates of binding parameters are themselves approximations.
To apply the method described by Sprague et al (2004) , we first measured FRAPs with different spot sizes and detected different recovery curves, demonstrating that diffusion contributed to the recovery. Consistent with this, recoveries were well fitted by the effective diffusion approximation, and this fit was in turn consistent with an independent fit using the full model (Sprague et al, 2004) . Fits were performed with the nlinfit routine in Matlab (The Math Works Inc., Natick, MA, USA), which for each fit yielded a standard error estimate on the parameter, essentially the effective diffusion constant, which describes recovery rate for the curve. These standard errors were in turn used to compute P-values for curve comparisons.
The effective diffusion constant predicted by these fits (D ACE1-GFP ) was significantly smaller than the free diffusion constant determined for unconjugated GFP (D GFP ). As DpM À1/3 , where M is the mass,
This yields a large estimate (1.4 MDa) for the mass of ACE1p-GFP, presuming no binding interactions. Therefore, the slowed recovery is more likely to be due to rapid binding interactions, as described by the process of effective diffusion.
To estimate association constants, we used the effective diffusion relationship (Sprague et al, 2004 )
where K a ¼ k on /k off is the association constant of binding and S eq is the equilibrium concentration of free binding sites. A range of 1-10 mM for S eq was estimated by calculating the molar concentration for 2.5 Â 10 7 base pairs of DNA in a diploid nucleus of 1 mm radius, assuming that either all or only 10% of sites are accessible. This enables an estimate of K a using both equation (1) Soumpasis (1983) to compute a predicted FRAP recovery curve (see also equations (7) and (8) in Sprague et al, 2004) . is the salt concentration of the surrounding milieu and N is the number of salt ions released from DNA on transcription factor binding (Manning, 1978) . If, in vivo, histones neutralize approximately half the DNA charge (Clark & Kimura, 1990) , then the number of salt ions released on transcription factor binding in vivo will be N/2 instead of N. Assuming that c, the salt concentration, does not change appreciably from in vivo to in vitro, then the factor of 1/2 in N must arise from a change in K a . Given the logarithmic relationship above, this implies that (K a in vivo) ¼ (K a in vitro) 1/2 .
